1. W. B. Siesser, Benjamin D. Sachs, A.J. Ramsey, T.D. Sotnikova, Jean-Martin Beaulieu, X. Zhang, M.G.Caron, Raul R. Gainetdinov, “Chronic SSRI Treatment Exacerbates Serotonin Deficiency in Humanized Tph2 Mutant Mice“, US National Library of Medicine [INTERNET] 2013 Jan 16, updated online 2012 Oct 1 [cited 2023 April 3]
2. FDA label Celexa [cited 2023 April 3]
3. Cuomo I, Kotzalidis GD, Caccia F, Danese E, Manfredi G, Girardi P. Citalopram-associated gambling: a case report. J Gambl Stud. 2014 Jun;30(2):467-73. doi: 10.1007/s10899-013-9360-2. PMID: 23385394. [cited 2023 April 3]
4. Fava GA, Offidani E. The mechanisms of tolerance in antidepressant action. Prog Neuropsychopharmacol Biol Psychiatry. 2011 Aug 15;35(7):1593-602. doi: 10.1016/j.pnpbp.2010.07.026. Epub 2010 Aug 20. PMID: 20728491. [cited 2023 April 3]
5. Bouwer CD, Harvey BH. Phasic craving for carbohydrate observed with citalopram. Int Clin Psychopharmacol. 1996 Dec;11(4):273-8. doi: 10.1097/00004850-199612000-00009. PMID: 9031994. [cited 2023 April 3]
6. Read J, Cartwright C, Gibson K. How many of 1829 antidepressant users report withdrawal effects or addiction? Int J Ment Health Nurs. 2018 Dec;27(6):1805-1815. doi: 10.1111/inm.12488. Epub 2018 Jun 5. PMID: 29873165. [cited 2023 April 3]
7. Davies J, Read J, A systemaatic review into the incidence, severity, and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors Journal Vol. 97 October 2019 [cited 2023 April 3]
8. Gautam M, Tripathi A, Deshmukh D, Gaur M. Cognitive Behavioral Therapy for Depression. Indian J Psychiatry. 2020;62(Suppl 2):S223-S229. doi:10.4103/psychiatry.IndianJPsychiatry_772_19 [cited 2023 April 3]
9. Yeung KS, Hernandez M, Mao JJ, Haviland I, Gubili J. Herbal medicine for depression and anxiety: A systematic review with assessment of potential psycho-oncologic relevance. Phytother Res. 2018 May;32(5):865-891. doi: 10.1002/ptr.6033. Epub 2018 Feb 21. PMID: 29464801; PMCID: PMC5938102. [cited 2023 April 3]
10. Sarris J, McIntyre E, Camfield DA. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence. CNS Drugs. 2013 Apr;27(4):301-19. doi: 10.1007/s40263-013-0059-9. Erratum in: CNS Drugs. 2013 Aug;27(8):675. Dosage error in article text. PMID: 23653088. [cited 2023 April 3]
11. Penckofer S, Kouba J, Byrn M, Estwing Ferrans C. Vitamin D and depression: where is all the sunshine?. Issues Ment Health Nurs. 2010;31(6):385-393. doi:10.3109/01612840903437657 [cited 2023 April 3]
12. Dirmaier J, Steinmann M, Krattenmacher T, Watzke B, Barghaan D, Koch U, Schulz H. Non-pharmacological treatment of depressive disorders: a review of evidence-based treatment options. Rev Recent Clin Trials. 2012 May;7(2):141-9. doi: 10.2174/157488712800100233. PMID: 22353197. [cited 2023 April 3]
13. Teicher MH, Glod CA, Cole JO. Antidepressant drugs and the emergence of suicidal tendencies. Drug Saf. 1993 Mar;8(3):186-212. doi: 10.2165/00002018-199308030-00002. PMID: 8452661. [cited 2023 March 30]
14. Sharbaf Shoar N, Fariba KA, Padhy RK. Citalopram. [Updated 2021 Dec 11]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK482222/ [cited 2023 April 3]
15. Sheffler ZM, Patel P, Abdijadid S. Antidepressants. [Updated 2023 May 26]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK538182/ [cited 2024 June 10]
16. Madhukar H. Trivedi, M.D., Maurizio Fava, M.D., Stephen R. Wisniewski, Ph.D. Michael E. Thase, M.D. Frederick Quitkin, M.D. Diane Warden, Ph.D., M.B.A. Louise Ritz, M.B.A.,+6 for the STAR*D Study Team Medication Augmentation after the Failure of SSRIs for Depression New England Journal of Medicine [published Mar 23, 2006] [cited 2024 June 10]